Deep Track Capital as of March 31, 2022
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 51 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novocure Ord Shs (NVCR) | 5.3 | $83M | 1.0M | 82.85 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.2 | $81M | 1.9M | 43.88 | |
| Travere Therapeutics (TVTX) | 5.2 | $81M | 3.1M | 25.77 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.2 | $81M | 517k | 155.67 | |
| Global Blood Therapeutics In | 5.1 | $80M | 2.3M | 34.64 | |
| Fate Therapeutics (FATE) | 5.0 | $78M | 2.0M | 38.77 | |
| Madrigal Pharmaceuticals (MDGL) | 4.9 | $77M | 786k | 98.12 | |
| Iveric Bio | 4.9 | $76M | 4.5M | 16.83 | |
| Alnylam Pharmaceuticals (ALNY) | 4.9 | $76M | 464k | 163.29 | |
| Keros Therapeutics (KROS) | 4.8 | $75M | 1.4M | 54.38 | |
| Kura Oncology (KURA) | 3.5 | $55M | 3.4M | 16.08 | |
| Chinook Therapeutics | 3.1 | $49M | 3.0M | 16.36 | |
| Beam Therapeutics (BEAM) | 2.8 | $44M | 764k | 57.30 | |
| Immunovant (IMVT) | 2.6 | $40M | 7.2M | 5.51 | |
| Repare Therapeutics Ord (RPTX) | 2.4 | $38M | 2.7M | 14.24 | |
| 4d Molecular Therapeutics In (FDMT) | 2.4 | $37M | 2.4M | 15.12 | |
| Agenus Com New | 2.2 | $34M | 14M | 2.46 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.2 | $34M | 1.5M | 21.95 | |
| Dyne Therapeutics (DYN) | 2.2 | $34M | 3.5M | 9.64 | |
| Jounce Therapeutics | 1.9 | $29M | 4.3M | 6.79 | |
| Esperion Therapeutics (ESPR) | 1.8 | $28M | 6.0M | 4.64 | |
| Kalvista Pharmaceuticals (KALV) | 1.6 | $26M | 1.7M | 14.74 | |
| Nkarta (NKTX) | 1.5 | $24M | 2.1M | 11.38 | |
| Dice Therapeutics | 1.5 | $24M | 1.3M | 19.13 | |
| Sage Therapeutics (SAGE) | 1.4 | $22M | 675k | 33.10 | |
| Tricida | 1.4 | $22M | 2.7M | 8.22 | |
| Miragen Therapeutics (VRDN) | 1.4 | $22M | 1.2M | 18.49 | |
| Silence Therapeutics Ads (SLN) | 1.2 | $18M | 952k | 19.00 | |
| Magenta Therapeutics | 1.0 | $16M | 5.4M | 2.90 | |
| Forma Therapeutics Hldgs SHS | 1.0 | $15M | 1.7M | 9.30 | |
| Fulcrum Therapeutics (FULC) | 1.0 | $15M | 650k | 23.65 | |
| Enanta Pharmaceuticals (ENTA) | 0.9 | $14M | 199k | 71.18 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $14M | 559k | 24.74 | |
| Gritstone Oncology Ord (GRTS) | 0.8 | $12M | 3.0M | 4.12 | |
| Century Therapeutics (IPSC) | 0.7 | $12M | 927k | 12.59 | |
| Hookipa Pharma Inc equity | 0.7 | $12M | 5.0M | 2.28 | |
| Passage Bio (PASG) | 0.7 | $11M | 3.4M | 3.10 | |
| Acumen Pharmaceuticals (ABOS) | 0.7 | $10M | 2.6M | 3.91 | |
| Prometheus Biosciences | 0.6 | $9.3M | 245k | 37.76 | |
| Gh Research Ordinary Shares (GHRS) | 0.6 | $9.1M | 499k | 18.29 | |
| Nektar Therapeutics Put Option (NKTR) | 0.5 | $8.1M | 1.5M | 5.39 | |
| Tenaya Therapeutics (TNYA) | 0.4 | $6.4M | 547k | 11.78 | |
| Assembly Biosciences | 0.4 | $6.2M | 3.0M | 2.06 | |
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $6.1M | 1.2M | 5.26 | |
| Atyr Pharma Com New (ATYR) | 0.4 | $5.5M | 1.0M | 5.35 | |
| Protagonist Therapeutics Put Option (PTGX) | 0.2 | $3.5M | 148k | 23.68 | |
| Relmada Therapeutics (RLMD) | 0.2 | $2.8M | 102k | 26.99 | |
| Vigil Neuroscience (VIGL) | 0.2 | $2.7M | 389k | 7.03 | |
| Verve Therapeutics (VERV) | 0.1 | $2.3M | 102k | 22.82 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $1.6M | 383k | 4.17 | |
| Rafael Hldgs Com Cl B (RFL) | 0.0 | $261k | 104k | 2.51 |
